Samsung Secures First Neuralink Chip Manufacturing Deal
Samsung Electronics has reportedly secured its first semiconductor manufacturing contract from Neuralink, Elon Musk’s brain-computer interface company. The agreement marks a significant milestone for Samsung Foundry as it expands into the rapidly emerging neurotechnology sector.
According to industry reports, Samsung will develop and manufacture Neuralink’s fourth-generation brain implant chip using its advanced 4-nanometer process technology. As a result, the partnership strengthens Samsung’s position in high-performance semiconductor manufacturing while expanding its relationship with Musk-led ventures.
Fourth-Generation Neuralink Chip Under Development
Reports indicate that Samsung began research and development work on the new chip in late 2025. Furthermore, the processor, internally known as “O1,” is designed to power Neuralink’s next generation of brain-computer interface systems.
The chip will support Neuralink’s efforts to enhance communication between the human brain and digital devices. In addition, the technology aims to improve the performance and capabilities of future neural implants used by patients with neurological conditions.
Sources suggest that Samsung has already started producing test chips. Meanwhile, initial shipments are expected during the first half of 2027. If testing proceeds successfully, mass production could begin later that year.
Partnership Expands Samsung’s Advanced Foundry Business
The Neuralink contract adds another high-profile customer to Samsung Foundry’s portfolio. Moreover, it highlights the company’s strategy of targeting advanced semiconductor applications beyond traditional consumer electronics and mobile devices.
Samsung already manufactures chips for several technology companies connected to Elon Musk’s business ecosystem. Therefore, the Neuralink agreement further deepens cooperation between the South Korean technology giant and Musk-led enterprises.
Industry analysts view the partnership as a strategic opportunity for Samsung to showcase its advanced manufacturing capabilities in a highly specialized field. Consequently, the deal could open doors to additional contracts involving medical technology, artificial intelligence, and next-generation computing systems.
Neurotechnology Market Gains Momentum
Neuralink continues to develop implantable brain-computer interfaces that allow users to control devices using neural signals. The company has already conducted human implant procedures and continues to advance research aimed at restoring communication and mobility capabilities for individuals with severe neurological conditions.
As investment in neurotechnology accelerates worldwide, demand for highly specialized semiconductor solutions is expected to increase. Therefore, Samsung’s entry into this segment positions the company to benefit from one of the technology industry’s most promising emerging markets. (
